SOFT TISSUE SARCOMAS
Clinical trials for SOFT TISSUE SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMAS trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial launches for targeted sarcoma treatment
Disease control Recruiting nowThis early-stage trial aims to find a safe and effective dose of two drugs—gemcitabine and nab-sirolimus—when used together. It is for adults with advanced leiomyosarcoma or other soft-tissue sarcomas that have specific genetic changes (TSC1 or TSC2 mutations) and have stopped re…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for tough cancers: trial tests Immune-Boosting drug with chemo
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called tislelizumab to standard chemotherapy works better for people with advanced soft tissue sarcoma. It will enroll 45 adults with specific types of sarcoma that cannot be removed by surgery or have spread. The main…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
Genetic clues could guide sarcoma chemo decisions
Knowledge-focused Recruiting nowThis study aims to validate a genetic test called CINSARC to see if it can predict how well patients with soft-tissue sarcoma will respond to chemotherapy and their long-term outcomes. It will observe about 205 adults with non-metastatic sarcoma who are scheduled to receive chemo…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC